Ichiro Ieiri

Expression of P-glycoprotein in Human Placenta: Relation to Genetic Polymorphism of the Multidrug Resistance (MDR)-1 Gene

Mizuho Tanabe, Ichiro Ieiri, Naoki Nagata et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 535 citations

Life Sciences, Genetics, Molecular Genetics +13

Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects

Soichiro Ito, Ichiro Ieiri, Mizuho Tanabe et al. · Pharmacogenetics · 2001 · 235 citations

Life Sciences, Genetics, Molecular Genetics +11

Pharmacokinetics of omeprazole (a substrate of CYP2C19) and comparison with two mutant alleles, CYP2C19m1 in exon 5 and CYP2C19m2 in exon 4, in Japanese subjects*

Ichiro Ieiri, Takahiro Kubota, Akinori Urae et al. · Clinical Pharmacology & Therapeutics · 1996 · 114 citations

Veterinary Medicine, Pharmacokinetics, Pharmacology +15

Safety, tolerability, and anti-fibrotic efficacy of the CBP/β-catenin inhibitor PRI-724 in patients with hepatitis C and B virus-induced liver cirrhosis: An investigator-initiated, open-label, non-randomised, multicentre, phase 1/2a study

Kiminori Kimura, Tatsuya Kanto, Shinji Shimoda et al. · EBioMedicine · 2022 · 55 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Reliability of the omeprazole hydroxylation index for CYP2C19 phenotyping: possible effect of age, liver disease and length of therapy

Miyuki Kimura, Ichiro Ieiri, Yukiko Wada et al. · British Journal of Clinical Pharmacology · 1999 · 40 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16